Patent competition interface developing countries von cheng thomas (4 Ergebnisse)

Autor
Titel
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (4)

  • Neu (4)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

  • Sprache: Englisch

    Verlag: Oxford University Press, 2021

    0192857355 / 9780192857354

    • Hardcover

    Anbieter: PBShop.store US, Wood Dale, IL, USAPBShop.store US

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 169,59

     Versand gratis 
    Versand innerhalb von USA

    Anzahl: 15 verfügbar

    HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

  • Sprache: Englisch

    Verlag: Oxford University Press, 2021

    0192857355 / 9780192857354

    • Hardcover

    Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes KönigreichPBShop.store UK

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 161,76

    EUR 7,88 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 15 verfügbar

    HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

  • Sprache: Englisch

    Verlag: Oxford Univ Pr, 2022

    0192857355 / 9780192857354

    • Hardcover

    Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 277,30

    EUR 14,58 Versand 
    Versand von Vereinigtes Königreich nach USA

    Anzahl: 2 verfügbar

    Hardcover. Zustand: Brand New. 520 pages. 9.57x6.46x1.61 inches. In Stock.

  • Sprache: Englisch

    Verlag: Oxford University Press Mär 2022, 2022

    0192857355 / 9780192857354

    • Hardcover

    Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

    Verkäufer/-in mit 5 Sternen
    Verkäufer/-in kontaktieren

    Zustand: Neu

    EUR 396,52

    EUR 30,50 Versand 
    Versand von Deutschland nach USA

    Anzahl: 1 verfügbar

    Buch. Zustand: Neu. Neuware - This book proposes an approach to the patent-competition interface for developing countries. It puts forward a theoretical framework after canvassing relevant policy considerations and examines the many reasons why patent protection is not essential for generating innovation incentives in developing countries. These include the tendency of the patent system to overcompensate innovators, the availability of other appropriation mechanisms for innovators to monetize their innovations, and the lack of appropriate technological capacity in many developing countries to take advantage of the incentives generated by the patent system. It also argues that developing countries with a small population need not pay heed to the impact of their patent system on the incentives of foreign innovators. It then proposes a classification of developing countries into production countries, technology adaptation countries, and proto-innovation countries and argues that dynamic efficiency considerations take on different meanings for developing countries depending on their technological capacities. For the vast majority of developing countries bereft of meaningful innovation capacity, foreign technology transfer is the main vehicle for technological progress. The chief dynamic policy consideration for these countries is hence incentives for technology transfer instead of innovation incentives. There are three main means of voluntary technology transfer: importation of technological goods, foreign direct investment, and technology licensing. Competition law regulation of patent exploitation practices interacts with these three means of technology transfer in different ways and an appropriate approach to the patent-competition interface for these countries needs to take these into account. Distilling all these considerations, the book proposes a development stage-specific approach to the patent-competition interface for developing countries. The approach is then applied to a number of patent exploitation practices, including unilateral refusal to deal, patent tying, excessive pricing for pharmaceuticals, reverse payment settlements, and restrictive licensing practices.